Pathological significance and classification of endolymphatic hydrops in otological disorders.


Journal

Nagoya journal of medical science
ISSN: 2186-3326
Titre abrégé: Nagoya J Med Sci
Pays: Japan
ID NLM: 0412011

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 19 08 2021
accepted: 15 09 2021
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: ppublish

Résumé

We summarize the presence of endolymphatic hydrops (EH) in otological disorders evaluated with magnetic resonance imaging (MRI) of temporal bones, and propose a classification of EH based on its pathological significance. A search of the literature published in English-language journals was performed using electronic databases, especially focusing on EH-related otological disorders. Clinical articles that contained the terms EH and contrast-MRI published from 2007 to the present, with relevant human temporal bone studies, were included. The following three main points are discussed based on the results in the relevant articles: i) otological disorders that present EH, ii) current grading for evaluation of EH on MRI, and iii) a proposed classification of EH based on its pathological significance. MRI evaluation revealed that EH exists extensively not only in ears with typical Meniere's disease (MD), but also in those with various other otological disorders. The etiological classification of EH helps to summarize ideas for determining the pathophysiology of otological disorders, while a therapeutic classification provides clues to their management. MRI evaluations of EH have led to breakthroughs in investigations of EH in otological disorders. Precise grading for evaluation and clarification of EH on MRI based on its pathological significance could provide keys to elucidating the pathophysiology of EH-related otological disorders.

Identifiants

pubmed: 36237884
doi: 10.18999/nagjms.84.3.497
pmc: PMC9529623
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-505

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest associated with this manuscript.

Références

Acta Otolaryngol. 2020 May;140(5):345-350
pubmed: 32027202
Acta Otolaryngol. 2013 Feb;133(2):123-9
pubmed: 23106485
Laryngoscope. 2012 Oct;122(10):2265-8
pubmed: 22996668
PLoS One. 2018 Dec 5;13(12):e0206891
pubmed: 30517123
Otol Neurotol. 2008 Apr;29(3):282-9
pubmed: 18223508
Acta Otolaryngol. 2020 Aug;140(8):626-631
pubmed: 32331506
AJNR Am J Neuroradiol. 2020 Mar;41(3):529-534
pubmed: 32029469
Auris Nasus Larynx. 2018 Feb;45(1):33-38
pubmed: 28256285
Front Neurol. 2019 Feb 04;10:46
pubmed: 30778329
Otol Neurotol. 2018 Dec;39(10):1229-1234
pubmed: 30303944
Eur Radiol. 2018 Jul;28(7):2916-2922
pubmed: 29564597
Otol Neurotol. 2015 Aug;36(7):1146-50
pubmed: 25522197
AJNR Am J Neuroradiol. 2018 Nov;39(11):2114-2119
pubmed: 30337432
Acta Otolaryngol. 2011 May;131(5):474-9
pubmed: 21198346
Otol Neurotol. 2017 Jun;38(5):774-779
pubmed: 28306649
Acta Otolaryngol. 2011 Jun;131(6):602-9
pubmed: 21344957
Front Surg. 2021 Feb 04;7:623078
pubmed: 33614701
BMJ Open. 2013 Feb 14;3(2):
pubmed: 23418296
Laryngoscope. 2007 Mar;117(3):415-20
pubmed: 17279053
Laryngoscope. 2018 Jul;128(7):1658-1662
pubmed: 29105767
J Neurol. 2020 Dec;267(Suppl 1):197-211
pubmed: 33201310
Eur Arch Otorhinolaryngol. 2022 Jan;279(1):169-173
pubmed: 33547924
Neuroradiology. 2019 Apr;61(4):421-429
pubmed: 30719545
Acta Otolaryngol. 2009 Nov;129(11):1169-74
pubmed: 19863306
Otol Neurotol. 2018 Mar;39(3):351-356
pubmed: 29287037
AJNR Am J Neuroradiol. 2014 Jul;35(7):1387-92
pubmed: 24524921
J Neurol. 2016 Apr;263 Suppl 1:S71-81
pubmed: 27083887
Magn Reson Med Sci. 2010;9(4):237-42
pubmed: 21187694
Magn Reson Med Sci. 2020 May 1;19(2):119-124
pubmed: 31061269
Eur Radiol. 2015 Oct;25(10):3043-9
pubmed: 25820480
J Vestib Res. 2015;25(1):1-7
pubmed: 25882471
Otol Neurotol. 2013 Sep;34(7):1210-4
pubmed: 23921917
Otol Neurotol. 2012 Aug;33(6):1040-5
pubmed: 22772006
Acta Otolaryngol. 2017 Mar;137(3):242-245
pubmed: 27676652
Eur Radiol. 2017 Aug;27(8):3138-3146
pubmed: 27999985
Otol Neurotol. 2013 Sep;34(7):1241-6
pubmed: 23921924
Otol Neurotol. 2012 Oct;33(8):1375-9
pubmed: 22918115
Laryngoscope. 2016 Jun;126(6):1446-50
pubmed: 26525170
Otol Neurotol. 2016 Aug;37(7):984-90
pubmed: 27380537
Ann Otol Rhinol Laryngol. 1987 Jul-Aug;96(4):438-45
pubmed: 3619290
Otol Neurotol. 2021 Jul 1;42(6):e643-e647
pubmed: 33606468
Acta Otolaryngol Suppl. 2009 Feb;(560):5-8
pubmed: 19221900
Otol Neurotol. 2016 Dec;37(10):1516-1521
pubmed: 27608418
Int Tinnitus J. 2004;10(2):137-43
pubmed: 15732511
Otol Neurotol. 2017 Dec;38(10):e539-e544
pubmed: 29135874
Front Neurol. 2021 Apr 22;12:647296
pubmed: 33967941
Otol Neurotol. 2017 Sep;38(8):1076-1080
pubmed: 28708796
PLoS One. 2015 Mar 13;10(3):e0120357
pubmed: 25768940
Auris Nasus Larynx. 2019 Dec;46(6):859-865
pubmed: 31076273
Otol Neurotol. 2005 Jan;26(1):74-81
pubmed: 15699723
Neuroradiology. 2011 Dec;53(12):1009-15
pubmed: 21221556

Auteurs

Michihiko Sone (M)

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tadao Yoshida (T)

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Satofumi Sugimoto (S)

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masumi Kobayashi (M)

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masaaki Teranishi (M)

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shinji Naganawa (S)

Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH